In the very process of conducting this research study, our group of authors was exposed to several shocking and inadmissible problematic situations. In one of the saddest cases, a young person died from not having received appropriate and timely care at the time this study was conducted. We stand in solidarity with individuals living with rare diseases alienated from mainstream healthcare. We sincerely hope that such situations cease without delay and that the human impact of these conditions is fully recognized.
Abstract
Rare diseases, defined as having a prevalence inferior to 1/2000, are poorly understood scientifically and medically. Appropriate diagnoses and treatments are scarce, adding to the burden of living with chronic medical conditions. The moral significance of rare disease experiences is often overlooked in qualitative studies conducted with adults living with rare diseases. The concept of morally problematic situations arising from pragmatist ethics shows promise in understanding these experiences. The objectives of this study were to (1) acquire an in-depth understanding of morally problematic situations experienced by adults living with rare diseases in the province of Québec and (2) to develop an integrative model of the concept of morally problematic situations. To this end, an online survey targeting this population was developed through a participatory action research project. Respondents provided 90 long testimonies on the most important morally problematic situations they faced, often in healthcare settings. An integrative model was developed based on various qualitative analyses of these testimonies and relevant literature. The integrative model showcases that morally problematic situations have causes (i.e., contextual and relational factors, personal factors, jeopardized valuations), have affective repercussions (i.e., emotions and feelings, internal tensions), prompt action (i.e., through empowerment strategies leading to the evolution of situations), and elicit outcomes (i.e., factual consequences, residual emotions and feelings, positive or negative resolutions). In sum, this study advances understanding of the moral experiences of adults living with rare diseases while proposing a comprehensive conceptual tool to guide future empirical bioethics research on moral experiences.
This is a preview of subscription content, access via your institution.


Data Availability
The datasets generated and analysed during the current study are not publicly available in order to protect respondents’ confidentiality.
Notes
Since individuals living with rare diseases are often confronted to diagnostic delays, those who self-identified with having one or more undiagnosed rare disease(s) were welcomed to participate to the study (Molster et al., 2016).
The results of the other survey sections are reported elsewhere (Quintal et al., unpublished work 2).
In the Discussion, the numbers and letters in parentheses refer to their equivalents in Fig. 2.
References
Adler, N. E., Epel, E. S., Castellazzo, G., & Ickovics, J. R. (2000). Relationship of subjective and objective social status with psychological and physiological functioning: Preliminary data in healthy, white women. Health Psychology, 19(6), 586–592. https://doi.org/10.1037/0278-6133.19.6.586
Aiguier, G., & Loute, A. (2016). L’intervention éthique en santé: Un apprentissage collectif. Nouvelles Pratiques Sociales, 28(2), 158–172. https://doi.org/10.7202/1041185ar
Åsbring, P., & Närvänen, A. L. (2003). Ideal versus reality: Physicians perspectives on patients with chronic fatigue syndrome (CFS) and fibromyalgia. Social Science & Medicine, 57(4), 711–720. https://doi.org/10.1016/S0277-9536(02)00420-3
Baarsma, M. E., Claassen, S. A., van der Horst, H. E., Hovius, J. W., & Sanders, J. M. (2022). Knowing the entire story—A focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease). BMC Primary Care, 23(139), 1–12. https://doi.org/10.1186/s12875-022-01736-5
Biesta, G. (2010). Pragmatism and the philosophical foundations of mixed methods research. In A. Tashakkori & C. Teddlie (Eds.), Sage handbook of mixed methods in social and behavioral research (pp. 95–118). Sage Publications.
Blease, C., Carel, H., & Geraghty, K. (2017). Epistemic injustice in healthcare encounters: Evidence from chronic fatigue syndrome. Journal of Medical Ethics, 43(8), 549–557. https://doi.org/10.1136/medethics-2016-103691
Bogart, K., Hemmesch, A., Barnes, E., Blissenbach, T., Beisang, A., & Engel, P. (2022). Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases. Orphanet Journal of Rare Diseases, 17(1), 1–18. https://doi.org/10.1186/s13023-022-02343-4
Bogart, K. R., & Irvin, V. L. (2017). Health-related quality of life among adults with diverse rare disorders. Orphanet Journal of Rare Diseases, 12(1), 1–9.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
Brendel, D. H., & Miller, F. G. (2008). A plea for pragmatism in clinical research ethics. The American Journal of Bioethics, 8(4), 24–31.
Carricaburu, D., & Pierret, J. (1995). From biographical disruption to biographical reinforcement: The case of HIV-positive men. Sociology of Health & Illness, 17(1), 65–88. https://doi.org/10.1111/1467-9566.ep10934486
Dewey, J. (2003). Oeuvres complètes: Tome 1, Reconstruction en philosophie. Editions Farrago.
Dewey, J., & Chipman, A. H. (1920). Letters from China and Japan. EP Dutton Company.
Epstein, E. G., & Hamric, A. B. (2009). Moral distress, moral residue, and the crescendo effect. Journal of Clinical Ethics, 20(4), 330–342.
European Organisation for Rare Diseases. (2005). Rare diseases: Understanding this public health priority. Eurordis. Retrieved November 18, 2022, from https://www.eurordis.org/wp-content/uploads/2009/12/princeps_document-EN.pdf
Fins, J. J., Bacchetta, M. D., & Miller, F. G. (1997). Clinical pragmatism: A method of moral problem solving. Kennedy Institute of Ethics Journal, 7(2), 129–145. https://doi.org/10.1353/ken.1997.0013
Forman, J., Taruscio, D., Llera, V. A., Barrera, L. A., Coté, T. R., Edfjäll, C., Gavhed, D., Haffner, M. E., Nishimura, Y., Posada, M., Tambuyzer, E., Groft, S. C., & Henter, J.-I. (2012). The need for worldwide policy and action plans for rare diseases. Acta Paediatrica, 101(8), 805–807.
Gallagher, S. (2014). Pragmatic interventions into enactive and extended conceptions of cognition. Philosophical Issues, 24(1), 110–126. https://doi.org/10.1111/phis.12027
Garrino, L., Picco, E., Finiguerra, I., Rossi, D., Simone, P., & Roccatello, D. (2015). Living with and treating rare diseases: Experiences of patients and professional health care providers. Qualitative Health Research, 25(5), 636–651. https://doi.org/10.1177/1049732315570116
Good, B. (1994). Medicine, rationality and experience: An anthropological perspective. Cambridge University Press.
Government of Canada. (1998, July 15), last modified May 24, 2017. Previous standard—ethnicity. Statistics Canada. Retrieved November 18, 2022, from https://www.statcan.gc.ca/en/concepts/definitions/previous/ethnicity2
Grut, L., & Kvam, M. H. (2013). Facing ignorance: People with rare disorders and their experiences with public health and welfare services. Scandinavian Journal of Disability Research, 15(1), 20–32. https://doi.org/10.1080/15017419.2011.645870
Hartman, L., Metselaar, S., Widdershoven, G., & Molewijk, B. (2019). Developing a ‘moral compass tool’ based on moral case deliberations: A pragmatic hermeneutic approach to clinical ethics. Bioethics, 33(9), 1012–1021. https://doi.org/10.1111/bioe.12617
Hitlin, S. (2003). Values as the core of personal identity: Drawing links between two theories of self. Social Psychology Quarterly, 66(2), 118–137. https://doi.org/10.2307/1519843
Hunt, M. R., & Carnevale, F. A. (2011). Moral experience: A framework for bioethics research. Journal of Medical Ethics, 37(11), 658–662. https://doi.org/10.1136/jme.2010.039008
Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development. (2010). Profile of rare diseases. In M. J. Field & T. F. Boat (Eds.), Rare diseases and orphan products: Accelerating research and development (pp. 41–72). National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK56184/
Jagosh, J., Macaulay, A. C., Pluye, P., Salsberg, J., Bush, P. L., Henderson, J., Sirett, E., Wong, G., Cargo, M., Herbert, C. P., Seifer, S. D., Green, L. W., & Greenhalgh, T. (2012). Uncovering the benefits of participatory research: Implications of a realist review for health research and practice. Milbank Quarterly, 90(2), 311–346. https://doi.org/10.1111/j.1468-0009.2012.00665.x
Jensen, B., Broesby-Olsen, S., Bindslev-Jensen, C., & Nielsen, D. S. (2019). Everyday life and mastocytosis from a patient perspective-a qualitative study. Journal of Clinical Nursing, 28(7–8), 1114–1124. https://doi.org/10.1111/jocn.14676
Jonsen, A. R., Siegler, M., & Winslade, W. (2010). Clinical ethics: A practical approach to ethical decisions in clinical medicine (7th ed.). McGraw Hill Professional.
Jonsen, A. R. (1990). Case analysis in clinical ethics. Journal of Clinical Ethics, 1(1), 63–66.
Kesselheim, A. S., McGraw, S., Thompson, L., O’Keefe, K., & Gagne, J. J. (2015). Development and use of new therapeutics for rare diseases: Views from patients, caregivers, and advocates. Patient, 8(1), 75–84.
Kleinman, A., & Benson, P. (2006). Culture, moral experience and medicine. The Mount Sinai Journal of Medicine, 73(6), 834–839.
Lanre-Abass, B. (2010). Racism and its presuppositions: Towards a pragmatic ethics of social change. Human Affairs, 20(4), 364–375. https://doi.org/10.2478/v10023-010-0037-5
Lanteigne, A., Genest, M., & Racine, E. (2021). The evaluation of pediatric-adult transition programs: What place for human flourishing? SSM: Mental Health, 1(100007), 1–8. https://doi.org/10.1016/j.ssmmh.2021.100007
Levinas, E. (2002). Useless suffering. In R. Bernasconi & D. Wood (Eds.), The provocation of Levinas (pp. 168–179). Routledge.
Martinent, G., Carrot, M., Chirac, A., Dupuis-Girod, S., Fargeton, A. E., Da Conceição, S. B., & Fourdrinoy, S. (2020). Hereditary hemorrhagic telangiectasia and health-related quality of life: A qualitative investigation. Quality of Life Research, 29(5), 1291–1299.
Matta, R. da. (1981). Relativizando: Uma introdução à antropologia social. Editora Vozes.
Miller, F. G., Fins, J. J., & Bacchetta, M. D. (1996). Clinical pragmatism: John Dewey and clinical ethics. Journal of Contemporary Health, Law & Policy, 13(1), 27–51.
Miller, F. G., Fletcher, J. C., & Fins, J. J., et al. (1997). Clinical pragmatism: A case method of moral problem solving. In J. C. Fletcher (Ed.), Introduction to clinical ethics, second edition (pp. 21–34). University Publishing Group.
Ministère de la Santé et des Services sociaux. (2022). Politique québécoise pour les maladies rares. Bibliothèque et Archives nationales du Québec. Retrieved July 4, 2022, from https://publications.msss.gouv.qc.ca/msss/document-003397/
Misak, C. (2013). The American pragmatists. Oxford University Press.
Molster, C., Urwin, D., Di Pietro, L., Fookes, M., Petrie, D., van der Laan, S., & Dawkins, H. (2016). Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet Journal of Rare Diseases, 11(1), 1–12.
Moreira, M. C. N. (2019). Trajectories and moral experiences of rare and chronic illness in biographies: A theoretical essay. Ciencia & Saude Coletiva, 24(10), 3651–3661. https://doi.org/10.1590/1413-812320182410.33532018
Morgan, A., Eccles, F. J. R., & Greasley, P. (2019). Experiences of living with dystonia. Disability and Rehabilitation, 43(7), 944–952.
Nowell, L. S., Norris, J. M., White, D. E., & Moules, N. J. (2017). Thematic analysis: Striving to meet the trustworthiness criteria. International Journal of Qualitative Methods, 16(1), 1–13. https://doi.org/10.1177/1609406917733847
O’Brien, B. C., Harris, I. B., Beckman, T. J., Reed, D. A., & Cook, D. A. (2014). Standards for reporting qualitative research: A synthesis of recommendations. Academic Medicine, 89(9), 1245–1251. https://doi.org/10.1097/ACM.0000000000000388
Pekarsky, D. (1990). Dewey’s conception of growth reconsidered. Educational Theory, 40(3), 283–294. https://doi.org/10.1111/j.1741-5446.1990.00283.x
Racine, E. (2007). HEC member perspectives on the case analysis process: A qualitative multi-site study. HEC Forum, 19(3), 185–206. https://doi.org/10.1007/s10730-007-9046-1
Racine, E. (2014). Pragmatism and the contribution of neuroscience to ethics. In T. Solymosi & J. R. Shook (Eds.), Neuroscience, neurophilosophy and pragmatism: Brains at work with the world (pp. 243–263). Palgrave Macmillan.
Racine, E. (2016). Can moral problems of everyday clinical practice ever be resolved? A proposal for integrative pragmatist approaches. In P. L. Rosenbaum, G. M. Ronen, E. Racine, J. Johannesen, & D. Bernard (Eds.), Ethics in child health: Principles and cases in neurodisability (pp. 33–48). Mac Keith Press.
Racine, E. (2022). How ethics liberates experience: Insights from pragmatist theory and contemporary research. Journal of Speculative Philosophy, 36(4), 517–536.
Racine, E., & Cascio, M. A. (2020). The false dichotomy between empirical and normative bioethics. AJOB Empirical Bioethics, 11(1), 5–7.
Racine, E., Kusch, S., Cascio, M. A., & Bogossian, A. (2021). Making autonomy an instrument: A pragmatist account of contextualized autonomy. Humanities and Social Sciences Communications, 8(1), 1–15.
Ryff, C. D. (1989). Happiness is everything, or is it? Explorations on the meaning of psychological well-being. Journal of Personality and Social Psychology, 57(6), 1069–1081.
Ryff, C. D., & Singer, B. H. (2008). Know thyself and become what you are: A eudaimonic approach to psychological well-being. Journal of Happiness Studies, 9(1), 13–39.
Shook, J. R. (2010). Pragmatism, pluralism, and public democracy. Revue française d’études américaines, 124(2), 11–28. https://doi.org/10.3917/rfea.124.0011
Vaismoradi, M., Turunen, H., & Bondas, T. (2013). Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nursing & Health Science, 15(3), 398–405. https://doi.org/10.1111/nhs.12048
von der Lippe, C., Diesen, P. S., & Feragen, K. B. (2017). Living with a rare disorder: A systematic review of the qualitative literature. Molecular Genetics & Genomic Medicine, 5(6), 758–773.
Witten, H., Savahl, S., & Adams, S. (2019). Adolescent flourishing: A systematic review. Cogent Psychology, 6(11640341), 1–16. https://doi.org/10.1080/23311908.2019.1640341
Acknowledgements
We would like to thank Pauline Lenfant-Koenig for formatting the manuscript. We would also like to thank Services de transcription Janie Babin for the transcription of recorded long testimonies. We thank members of the Pragmatic Health Ethics Research Unit for their insightful comments on this manuscript in addition to Christine Yergeau, Emilia Liana Falcone, Gail Ouellette, Alexandre Morin-Farcy, and Alex Galli for their input on the study design. We would like to thank all survey respondents for sharing their rich life experiences relating to their rare diseases.
Funding
This study was conducted with the support of doctoral research scholarships from the Canadian Institutes of Health Research and from the Fonds de recherche du Québec—Santé (AQ), by graduate student awards from Université de Montréal (AQ), and by a career award and grant from the Fonds de recherche du Québec—Santé (FRQ-S) (ER).
Author information
Authors and Affiliations
Contributions
AQ and ER designed most of the study and secured funding. AQ, ÉH, and ER analyzed the survey data. AQ was responsible for writing the manuscript. CH, IC, ADG, and YB significantly contributed to improving the study design, interpreting its results, and enriched the manuscript. All authors have approved the final manuscript. AQ and ER accept full responsibility for the finished work, had access to the data and controlled the decision to publish.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Ethical Approval
This study was approved by the human subject ethics committee of our institution (2021-1080). It complied with the Standards on Research Ethics and Scientific Integrity of the Fonds de recherche du Québec—Santé and the Tri-Council Policy Statement 2—Ethical Conduct for Research Involving Humans of the Panel on Research Ethics of the Canadian government. Survey respondents gave informed consent before participating to the study.
Consent to Participate
Free and informed written consent was obtained from all survey respondents. The respondents have given written consent to the inclusion of material pertaining to themselves in the manuscript, acknowledging that they cannot be identified in the manuscript and that their statements are fully anonymized.
Standards of Reporting
The article is reported in accordance with the Standards for Reporting Qualitative Research of O’Brien et al. (2014).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Quintal, A., Hotte, É., Hébert, C. et al. Understanding Rare Disease Experiences Through the Concept of Morally Problematic Situations. HEC Forum (2023). https://doi.org/10.1007/s10730-023-09511-4
Accepted:
Published:
DOI: https://doi.org/10.1007/s10730-023-09511-4